Trust Company’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$442 Hold
2
– – ﹤0.01% 778
2026
Q2
$390 Hold
2
– – ﹤0.01% 810
2026
Q1
$449 Hold
2
– – ﹤0.01% 743
2025
Q4
$482 Buy
+2
New +$511 ﹤0.01% 705

Other funds holding RMD

Trust Company's RMD Position: Q3 2026 in Review

Trust Company held its ResMed (RMD) position steady in Q3 2026 at 2 shares worth $442. The position accounts for ﹤0.01% of the portfolio, ranked #778.

Trust Company first reported a position in RMD in Q4 2025 and has held it in 4 quarters since. The position peaked at $482 in Q4 2025. 880 funds tracked by Wall St. Rank hold RMD as of Q3 2026.

  • Trust Company held 2 shares of ResMed worth $442 as of Q3 2026.
  • Trust Company left its ResMed share count unchanged in Q3 2026.
  • ResMed made up ﹤0.01% of Trust Company's portfolio in Q3 2026, its #778 holding.
  • Trust Company first reported a position in ResMed in Q4 2025 and has held it in 4 quarters since.
  • Trust Company's ResMed position peaked at $482 in Q4 2025.
  • 880 funds tracked by Wall St. Rank held ResMed as of Q3 2026.

Based on Trust Company's 13F filing for Q3 2026, filed 9 Oct 2026.